Search research articles
Contact Us
Filters
Showing results (71-80 of 123) with videos related to
Page
of 13
Sort By:
Alimentary Pharmacology & Therapeutics
|
September 15, 2015
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases
K Papamichael, T Van Stappen, V Jairath, et al.
Gastroenterology
|
March 29, 2016
Efficient Early Drug Development for Ulcerative Colitis
Reena Khanna, Vipul Jairath, Niels Vande Casteele, et al.
Neurobiology of Aging
|
April 30, 1998
Presenilin 1 is actively degraded by the 26S proteasome
P E Fraser, G Levesque, G Yu, et al.
The Cochrane Database of Systematic Reviews
|
August 9, 2016
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease
Reena Khanna, Sigrid A Nelson, Brian G Feagan, et al.
Neurobiology of Disease
|
September 25, 1998
Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein
M Citron, C B Eckman, T S Diehl, et al.
Alimentary Pharmacology & Therapeutics
|
October 29, 2014
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
R Khanna, G Zou, G D'Haens, et al.
Human Molecular Genetics
|
May 23, 1998
Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease
N Brindle, Y Song, E Rogaeva, et al.
The Cochrane Database of Systematic Reviews
|
May 26, 2017
Histologic scoring indices for evaluation of disease activity in ulcerative colitis
Mahmoud H Mosli, Claire E Parker, Sigrid A Nelson, et al.
Gut
|
June 22, 2014
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
Krisztina B Gecse, Willem Bemelman, Michael A Kamm, et al.
Inflammatory Bowel Diseases
|
August 20, 2014
Assessment of histologic disease activity in Crohn's disease: a systematic review
Amirkaveh Mojtahed, Reena Khanna, William J Sandborn, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 123) with videos related to
Sort By:
Page
of 13
Alimentary Pharmacology & Therapeutics
|
September 15, 2015
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases
K Papamichael, T Van Stappen, V Jairath, et al.
Gastroenterology
|
March 29, 2016
Efficient Early Drug Development for Ulcerative Colitis
Reena Khanna, Vipul Jairath, Niels Vande Casteele, et al.
Neurobiology of Aging
|
April 30, 1998
Presenilin 1 is actively degraded by the 26S proteasome
P E Fraser, G Levesque, G Yu, et al.
The Cochrane Database of Systematic Reviews
|
August 9, 2016
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease
Reena Khanna, Sigrid A Nelson, Brian G Feagan, et al.
Neurobiology of Disease
|
September 25, 1998
Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein
M Citron, C B Eckman, T S Diehl, et al.
Alimentary Pharmacology & Therapeutics
|
October 29, 2014
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
R Khanna, G Zou, G D'Haens, et al.
Human Molecular Genetics
|
May 23, 1998
Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease
N Brindle, Y Song, E Rogaeva, et al.
The Cochrane Database of Systematic Reviews
|
May 26, 2017
Histologic scoring indices for evaluation of disease activity in ulcerative colitis
Mahmoud H Mosli, Claire E Parker, Sigrid A Nelson, et al.
Gut
|
June 22, 2014
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
Krisztina B Gecse, Willem Bemelman, Michael A Kamm, et al.
Inflammatory Bowel Diseases
|
August 20, 2014
Assessment of histologic disease activity in Crohn's disease: a systematic review
Amirkaveh Mojtahed, Reena Khanna, William J Sandborn, et al.
Page
of 13